FDA Inspection 976264 — Octapharma Plasma, Inc.

Octapharma Plasma, Inc. — FEI 3007554647

The FDA completed an inspection of Octapharma Plasma, Inc. on June 2, 2016 in Virginia Beach, VA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
June 2, 2016
Fiscal Year
2016
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Virginia Beach, VA (United States)